Gilead Sciences

Intern - Formulation and Process Development

Posted on: 16 Sep 2022

Foster City, CA

Job Description

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.

Intern - Formulation and Process Development

As a Gilead intern you will contribute to high-impact meaningful projects that will not only further advance our company’s mission but will allow you to gain real world experience at one of the most innovative organizations in the world.  You will also have opportunities to participate in special events including professional development and leadership presentations, social/network building activities and local community volunteer programs.

Key Responsibilities will include, but are not limited to the following:

Under general supervision, you will be responsible for execution of laboratory experiments and conducting literature searches
Projects typically involve addressing various chemistry and/or engineering challenges that are encountered as part of formulation and process development, these projects often focus on issues related to the development of solid oral dosage forms (e.g., tablets) but may also relate to the development of formulations for delivery by injection and/or inhalation
Maintain an electronic laboratory notebook to capture the data and observations that you collect
Organize, summarize, and present the data to a team periodically to analyze the results and design additional experiments to further understand the observations
Showcase your work with a final poster board and/or oral presentation near the conclusion of your internship

Required Qualifications:

Must be at least 18 years old
Must have a minimum GPA of 2.8
Authorized to work in the United States without Sponsorship now or in the future
Must be currently enrolled as a full-time student in a Bachelor’s/Masters/MBA/PhD program at an accredited US based university or college

Must be a Rising Sophomore, Junior, or Senior in undergrad or a Graduate or Doctoral Student
Must be enrolled full-time in the Fall Semester at an accredited university/college after the completion of the internship
Must be able to complete a 10-12 consecutive week internship between May and August
Must be able to relocate if necessary and work at the designated site for the duration of the internship
Must show proof of full COVID-19 vaccination and first booster shot  

Preferred Qualifications:

Enrolled in a Graduate or Undergraduate Program with a Major in Pharmaceutical Sciences, Chemistry, Chemical/Biochemical Engineering, Biochemistry, or a related scientific discipline, including associated laboratory coursework
Proficiency with MS Office Suite
Ability to identify issues, seek solutions, and communicate effectively
Ability to work both independently and collaboratively
Demonstrated commitment to inclusion and diversity in the workplace
Efficient, organized, and able to handle short timelines in a fast-paced environment

Gilead Core Values:

Integrity (Doing What’s Right)
Inclusion (Encouraging Diversity)
Teamwork (Working Together)
Excellence (Being Your Best)
Accountability (Taking Personal Responsibility)

Gilead Sciences

Foster City, CA

Gilead Sciences, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical needs in the United States, Europe, and internationally. The company’s products include Biktarvy, Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Atripla, and Truvada for the treatment of human immunodeficiency virus (HIV) infection in adults; and Vosevi, Vemlidy, Epclusa, Harvoni, and Viread products for treating liver diseases.

It also provides Yescarta, a chimeric antigen receptor T cell therapy for adult patients with relapsed or refractory large B-cell lymphoma; Zydelig, a kinase inhibitor; Letairis, an oral formulation of an endothelin receptor antagonist for pulmonary arterial hypertension; Ranexa, a tablet to treat chronic angina; and AmBisome, an antifungal agent to treat serious invasive fungal infections. In addition, the company offers its products under the name Cayston, Emtriva, Hepsera, Sovaldi, and Tybost. Further, it develops product candidates for the treatment of HIV/AIDS and liver diseases, hematology/oncology, inflammation/respiratory diseases, and others.

The company markets its products through its commercial teams; and in conjunction with third-party distributors and corporate partners. Gilead Sciences, Inc. has collaboration agreements with Bristol-Myers Squibb Company; Janssen Sciences Ireland UC; Japan Tobacco Inc.; Galapagos NV; Scholar Rock Holding Corporation; Tango Therapeutics; National Cancer Institute; Pfizer, Inc.; Sangamo Therapeutics, Inc.; Gadeta B.V.; HiFiBiO Therapeutics; Agenus Inc.; HOOKIPA Pharma Inc.; Goldfinch Bio, Inc.; and insitro Inc. The company was founded in 1987 and is headquartered in Foster City, California.